US2004023375A1PendingUtilityA1
Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays
Est. expiryJul 30, 2022(expired)· nominal 20-yr term from priority
G01N 33/5011G01N 2800/52C12N 2503/02C12N 5/0693
39
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
An improved method for preparing a cell culture is disclosed. The method includes culturing a multicellular tissue explant in the presence of growth medium that is substantially free of enzymes capable of digesting the explant and, subsequently, removing the explant at a predetermined time.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method for preparing a cell culture, the method comprising:
culturing a multicellular tissue explant in the presence of growth medium that is substantially free of enzymes capable of digesting said explant; and removing said multicellular tissue explant from said growth medium at a predetermined time, thereby to produce a cell culture monolayer.
2 . The method of claim 1 , further comprising preparing a cell suspension from said cell culture monolayer.
3 . The method of claim 1 , further comprising inoculating cells from said cell culture monolayer into at least one segregated site.
4 . The method of claim 1 , wherein said tissue explant comprises tumor tissue.
5 . The method of claim 1 , further comprising the step of mechanically fragmenting the multicellular tissue explant in a medium that is free of enzymes that are capable of digesting said explant.
6 . The method of claim 1 , comprising the step of removing said multicellular tissue explant from said growth medium prior to an emergence of a substantial number of stromal cells from said explant, thereby to produce a cell culture monolayer that is predominantly composed of non-stromal cells.
7 . The method of claim 6 wherein said non-stromal cells comprise tumor cells.
8 . The method of claim 1 , wherein the cell culture monolayer exhibits a percent confluency, and wherein the step of removing said multicellular tissue explant comprises removing said multicellular tissue explant at about 10 to about 50 percent confluency.
9 . The method of claim 8 , wherein the step of removing said multicellular tissue explant comprises removing said multicellular tissue explant at about 15 to about 25 percent confluency.
10 . The method of claim 8 , wherein the step of removing said multicellular tissue explant comprises removing said multicellular tissue explant at about 20 percent confluency.
11 . A cell culture preparation resulting from the method of claim 1 or 10 .
12 . A method for determining the chemosensitivity of a tissue in a patient to an agent, the method comprising the steps of:
(a) culturing a multicellular tissue explant from a patient in the presence of growth medium that is substantially free of enzymes capable of digesting said explant so as to produce a cell culture monolayer; (b) removing said multicellular tissue explant from said growth medium at a predetermined time; (d) inoculating cells from said cell culture monolayer into at least one segregated site; (e) exposing said segregated site to at least one agent; and (f) assessing the chemosensitivity of said cells in said segregated site, wherein said chemosensitivity of said cells is indicative of the chemosensitivity of the tissue in the patient.
13 . The method of claim 12 , wherein said multicellular tissue explant comprises tumor tissue.
14 . The method of claim 13 , wherein the cell culture monolayer exhibits a percent confluency, and wherein the step of removing said multicellular tissue explant comprises removing said multicellular tissue explant at about 10 to about 50 percent confluency.
15 . The method of claim 14 , wherein the step of removing said multicellular tissue explant comprises removing said multicellular tissue explant at about 15 to about 25 percent confluency.
16 . The method of claim 14 , wherein the step of removing said multicellular tissue explant comprises removing said multicellular tissue explant at about 20 percent confluency.
17 . A method for determining the efficacy of an agent, the method comprising the steps of:
(a) preparing a cell culture in accordance with claim 3; (b) exposing said segregated site to at least one agent; and (c) assessing the chemosensitivity of said cells in said segregated site, thereby to determine the efficacy of said agent.
18 . The method of claim 17 , wherein the cell culture monolayer exhibits a percent confluency, and wherein the step of removing said multicellular tissue explant comprises removing said multicellular tissue explant at about 15 to about 25 percent confluency.
19 . The method of claim 18 , wherein the step of removing said multicellular tissue explant comprises removing said multicellular tissue explant at about 20 percent confluency.
20 . A method for identifying an agent having anti-tumorogenic effect, the method comprising the steps of:
(a) preparing a cell culture in accordance with claim 4; (b) inoculating cells from said cell culture monolayer into a plurality of segregated sites (c) exposing each of said segregated sites to an agent; and (d) assessing the chemosensitivity of said cells in each of said segregated sites, thereby to identify an agent having an anti-tumorogenic effect.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.